Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | S-adenosylmethionine decarboxylase-ornithine decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Trichomonas vaginalis | pyridoxal-dependent decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Brugia malayi | flavodoxin family protein | 0.0116 | 0.3358 | 0.2472 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0122 | 0.3668 | 1 |
Toxoplasma gondii | diaminopimelate decarboxylase | 0.0134 | 0.4217 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0116 | 0.3358 | 0.7965 |
Trypanosoma brucei | ornithine decarboxylase | 0.0134 | 0.4217 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0116 | 0.3358 | 0.4303 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Mycobacterium leprae | PROBABLE DIAMINOPIMELATE DECARBOXYLASE LYSA (DAP DECARBOXYLASE) | 0.0052 | 0.0188 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0116 | 0.3358 | 0.8757 |
Brugia malayi | Pyridoxal-dependent decarboxylase, pyridoxal binding domain containing protein | 0.0134 | 0.4217 | 0.3445 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0116 | 0.3358 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0116 | 0.3358 | 0.8757 |
Plasmodium falciparum | S-adenosylmethionine decarboxylase/ornithine decarboxylase | 0.0134 | 0.4217 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0251 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0116 | 0.3358 | 0.8757 |
Chlamydia trachomatis | sulfite reductase | 0.0072 | 0.1178 | 0.5 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0116 | 0.3358 | 0.2472 |
Leishmania major | p450 reductase, putative | 0.0116 | 0.3358 | 0.4303 |
Giardia lamblia | Ornithine decarboxylase | 0.0134 | 0.4217 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0122 | 0.3668 | 1 |
Loa Loa (eye worm) | pyridoxal-dependent decarboxylase | 0.0134 | 0.4217 | 0.3445 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.3358 | 0.2472 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0116 | 0.3358 | 0.5 |
Entamoeba histolytica | ornithine decarboxylase, putative | 0.0134 | 0.4217 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.0188 | 0.0446 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0116 | 0.3358 | 0.5 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0116 | 0.3358 | 0.5 |
Leishmania major | ornithine decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Onchocerca volvulus | 0.0134 | 0.4217 | 0.5 | |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0072 | 0.1178 | 0.2173 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.0134 | 0.4217 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0059 | 0.053 | 0.0136 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0116 | 0.3358 | 0.9027 |
Brugia malayi | FAD binding domain containing protein | 0.0116 | 0.3358 | 0.2472 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0116 | 0.3358 | 0.8757 |
Mycobacterium tuberculosis | Diaminopimelate decarboxylase LysA (DAP decarboxylase) | 0.0134 | 0.4217 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.0122 | 0.3668 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0251 | 1 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0086 | 0.1859 | 0.4315 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0116 | 0.3358 | 0.4303 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0103 | 0.271 | 0.6428 |
Mycobacterium ulcerans | diaminopimelate decarboxylase LysA | 0.0134 | 0.4217 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.